949014-42-0

Usage

Uses

Used in Pharmaceutical Industry:
Benzoic acid, 5-bromo-2-fluoro-4-methoxy-, is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with improved therapeutic properties and reduced side effects.
Used in Agrochemical Industry:
In the agrochemical industry, Benzoic acid, 5-broMo-2-fluoro-4-Methoxy- is utilized as a precursor for the synthesis of pesticides and other agrochemicals. Its presence in these products can enhance their effectiveness in controlling pests and diseases in agriculture.
Used in Organic Synthesis:
Benzoic acid, 5-bromo-2-fluoro-4-methoxy-, is used as an intermediate in organic synthesis. Its functional groups enable the formation of a wide range of complex organic molecules, which can be further utilized in various applications, including the development of new materials and the synthesis of specialty chemicals.
Used in Antimicrobial Applications:
Due to its potential antimicrobial properties, Benzoic acid, 5-broMo-2-fluoro-4-Methoxy- is studied for use in antimicrobial applications. It can be incorporated into various products, such as disinfectants and sanitizers, to help control the growth of harmful microorganisms and prevent the spread of infections.
Used in Anticancer Research:
Benzoic acid, 5-bromo-2-fluoro-4-methoxy-, is being investigated for its potential anticancer properties. Its unique structure may allow it to target and inhibit the growth of cancer cells, making it a promising candidate for the development of new cancer therapies.
Used in Precursor for Complex Organic Molecules:
Benzoic acid, 5-broMo-2-fluoro-4-Methoxyserves as a precursor for the preparation of complex organic molecules. Its functional groups can be further modified and utilized in the synthesis of advanced materials, pharmaceuticals, and other specialty chemicals, contributing to the advancement of various industries.

Upstream product

• 394-42-3 2-fluoro-4-methoxy-benzoic acid 

Relevant academic research and scientific papers

Structure-Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi

Chagas disease is a neglected parasitic disease caused by the parasitic protozoan Trypanosoma cruzi and currently affects around 8 million people. Previously, 2-isopropyl-5-(4-methoxy-3-(pyridin-3-yl)phenyl)-4,4-dimethyl-2,4-dihydro-3H-pyrazol-3-one (NPD-0227) was discovered to be a sub-micromolar inhibitor (pIC50=6.4) of T. cruzi. So far, SAR investigations of this scaffold have focused on the alkoxy substituent, the pyrazolone nitrogen substituent and the aromatic substituent of the core phenylpyrazolone. In this study, modifications of the phenyldihydropyrazolone scaffold are described. Variations were introduced by installing different substituents on the phenyl core, modifying the geminal dimethyl and installing various bio-isosteres of the dihydropyrazolone group. The anti T. cruzi activity of NPD-0227 could not be surpassed as the most potent compounds show pIC50 values of around 6.3. However, valuable additional SAR data for this interesting scaffold was obtained, and the data suggest that a scaffold hop is feasible as the pyrazolone moiety can be replaced by a oxazole or oxadiazole with minimal loss of activity.

PROCESS FOR PRODUCTION OF 4-OXOQUINOLINE COMPOUND

The present invention provides a compound useful as a synthetic intermediate for an anti-HIV agent having an integrase inhibitory activity, a production method thereof, and a production method of an anti-HIV agent using the synthetic intermediate. Specifi